-
DISEASE BURDEN AND HEALTHCARE UTILIZATION AFTER DIAGNOSIS OF NEUROFIBROMATOSIS TYPE 1 AND PLEXIFORM NEUROFIBROMAS (NF1-PN) IN SWEDISH PEDIATRIC PATIENTS: A REGISTRY-BASED STUDY
Aug 11, 2026, 17:16 PM -
COST-UTILITY OF SOX WITH BEVACIZUMAB IN COLORECTAL CANCER AMONG INDIAN POPULATION
Aug 11, 2026, 17:16 PM -
WHAT DRIVES POSITIVE NICE HEALTHTECH DECISIONS? A REVIEW OF ECONOMIC EVALUATION EVIDENCE FROM RECENT APPRAISALS
Aug 11, 2026, 17:16 PM -
EVOLUTION OF SOCIAL MEDIA CONVERSATIONS ABOUT OBESITY AND GLP-1 TREATMENTS IN FRANCE BETWEEN 2016 AND 2026 : A SOCIAL LISTENING STUDY
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF FINERENONE FOR CHINESE PATIENTS WITH HEART FAILURE AND LEFT VENTRICULAR EJECTION FRACTION (LVEF) =40%
Aug 11, 2026, 17:16 PM -
INCREASED RATES OF EMERGENCY CARE IN PEOPLE WITH IDIOPATHIC INFLAMMATORY MYOPATHIES: A POPULATION-BASED COHORT IN ENGLAND 2002 TO 2021
Aug 11, 2026, 17:16 PM -
A MODEL EXPLAINER AGENT TO REDUCE THE COMPREHENSION BURDEN ON HTA ASSESSORS REVIEWING ECONOMIC MODEL SUBMISSIONS: A CASE STUDY IN RARE DISEASE
Aug 11, 2026, 17:16 PM -
A FACTUAL CHECK THAT CANNOT REACH THE REASONING: THE FACTUAL-ACCURACY PARADOX
Aug 11, 2026, 17:16 PM -
EMERGING TRENDS IN HEALTH TECHNOLOGY ASSESSMENT, PRICING, AND REIMBURSEMENT: A STRUCTURED REVIEW OF 2025-2026 GLOBAL POLICY DEVELOPMENTS
Aug 11, 2026, 17:16 PM -
THE PATIENT JOURNEY IN PULMONARY FIBROSIS IN GREECE: DIAGNOSTIC PATHWAYS, DELAYS, AND EARLY MANAGEMENT
Aug 11, 2026, 17:16 PM -
DOES THE ELIGIBILITY RULE, NOT THE DRUG EFFECT, SET THE AFFORDABLE PRICE? A DIALYSIS-REVEALED COST-UTILITY ANALYSIS OF TOLVAPTAN IN ADPKD
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS AND UNCERTAINTY ANALYSIS OF EBOLA VACCINATION STRATEGIES IN CHILDREN AND ADOLESCENTS
Aug 11, 2026, 17:16 PM -
REAL-WORLD EVALUATION OF SGLT2 INHIBITORS IN HEART FAILURE WITH REDUCED EJECTION FRACTION: A RETROSPECTIVE COHORT STUDY
Aug 11, 2026, 17:16 PM -
IS EQ-5D-5L FULL HEALTH UNIVERSAL? EVIDENCE FROM THE EQ-DAPHNIE DATASET
Aug 11, 2026, 17:16 PM -
PRIOR EXPERIENCE DOES NOT MODIFY THE MOTIVATIONAL OR INHIBITORY COMPONENTS OF PREDISPOSITION TO TELEMEDICINE ADOPTION: MULTIGROUP EVIDENCE FOR BUILDING TECHNOLOGICAL READINESS IN THE BRAZILIAN AMAZON
Aug 11, 2026, 17:16 PM -
MEETING REGULATORY TARGETS, MISSING REIMBURSEMENT: EVIDENCE OF A SYSTEMATIC ENDPOINT MISMATCH IN PULMONARY ARTERIAL HYPERTENSION
Aug 11, 2026, 17:16 PM -
THRESHOLD SENSITIVITY ANALYSIS OF ADJUVANT TRASTUZUMAB IN HER2-POSITIVE EARLY BREAST CANCER IN INDIA
Aug 11, 2026, 17:16 PM -
QUANTIFYING PATIENT PREFERENCES FOR TYPE 2 DIABETES TREATMENTS AMONGST INDIVIDUALS IN CHINA: A DISCRETE CHOICE EXPERIMENT
Aug 11, 2026, 17:16 PM -
POTENTIAL IMPACT OF U.S MFN PRICING ON EX-US PRODUCT LAUNCH AND WITHDRAWAL STRATEGIES
Aug 11, 2026, 17:16 PM -
ADDRESSING EQ-5D CEILING EFFECTS THROUGH A DISEASE-SPECIFIC SYMPTOM THRESHOLD: A PATIENT-LEVEL ANALYSIS INFORMING THE NICE APPRAISAL OF DUPILUMAB IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
Aug 11, 2026, 17:16 PM
